Carlin V. Okerberg

PF-1355, a Mechanism-Based Myeloperoxidase Inhibitor, Prevents Immune Complex Vasculitis and Anti–Glomerular Basement Membrane Glomerulonephritis

Wei Zheng, Roscoe L. Warner, Roger B. Ruggeri et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 96 citations

Life Sciences, Immunology, Pharmacology +17

The Morphology of Smoke Inhalation Injury in Sheep

Gene B. Hubbard, Paulette C. Langlinais, Takeshi Shimazu et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 1991 · 89 citations

Veterinary Medicine, Pathobiology, Toxicology +17

Histopathologic and Immunohistochemical Features in Human Skin after Exposure to Nitrogen and Sulfur Mustard

Kathleen J. Smith, William J. Smith, Tracey A. Hamilton et al. · American Journal of Dermatopathology · 1998 · 87 citations

Medicine, Dermatology, Pathology +15

Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases

Roger B. Ruggeri, Leonard Buckbinder, Scott W. Bagley et al. · Journal of Medicinal Chemistry · 2015 · 57 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy

Stephen Orena, Tristan S. Maurer, Li She et al. · Frontiers in Pharmacology · 2013 · 52 citations · Full text

Medicine, Endocrinology, Pharmacology +16